Clinical Investigate Site Network Market Size, Share, Growth, Trends | Report 2022-2030
The global clinical investigative site network market is anticipated to reflect a considerable growth rate across the forecast period. The growth is due to the access to sites and the expanding global reach of clinical trials. Clinical investigative site networks, defined as a collection of independent clinical sites based on particular qualifying criteria that work as one entity, could be a new strategy for reducing the rise in R&D costs. The clinical investigative site network benefits the sponsors’ works through a single central administrative team, which cuts down on interactions and streamlines study communication instead of using numerous clinical administration offices.
A central administrative team monitors the entire network in accordance with established network protocols. The regulatory division of the central administration staff starts the process of regulatory preparedness, which entails the development of the informed consent document (ICD) and the institutional/ethical review board (IRB) review procedure. Networks frequently use a central IRB for the network's whole membership, which must adhere to 21 CFR 56.
Clinical trials were placed on hold as the pandemic started in order to slow its spread. However, due to the urgent need for vaccines, diagnostics, and therapies, the clinical trials were restarted by employing social distancing techniques. To support the clinical trials of COVID-19 vaccines and treatments, public organizations across the globe invested much in research and development. For instance, the Oxford/AstraZeneca COVID-19 vaccine's development received USD 119.1 million from the U.K. government as of February 2022. This is expected to have a positive impact on clinical investigative site network market.
The oncology segment is anticipated to hold the highest market share in the clinical investigative site network market owing to increasing research on novel cancer drug therapies. The major driver of the segment's growth is the disease's high prevalence, which increases the demand for research on it. The incidence of cancer is also rising as a result of a sedentary lifestyle, which increases the need for cancer trials in research.
The clinical investigative site network market in Asia Pacific is expected to witness the most lucrative growth in the forecast period, owing to the ease of regulatory compliance, low study costs, and increasing patient population. Furthermore, the region has become a hotspot for conducting clinical trials. For instance, a total of 125,918 registered clinical trials were conducted in Asia, according to a 2019 NIH study. These composed around 28.5% of all clinical trials that were registered. In Asia, Japan hosted (30.8%) of the trials, followed by China (21.1%) and India (14.3%).
The key market players include ICON plc, MERIDIAN CLINICAL RESEARCH, IQVIA Inc., Clinedge, WCG, ClinChoice, Access Clinical Research, FOMAT Medical Research INC., SGS, KV Clinical, SMO-Pharmina, Xylem Clinical Research, Aurum Clinical Research. They are adopting various strategies like merger and acquisition, collaboration, and expansion. For instance, Meridian clinical research, a leading multi-specialty investigative research network acquired Sterling Research Group. With the addition of the three Cincinnati locations belonging to Sterling, the company currently has 27 locations nationwide.
Market Segmentation
Chapter 1 Introduction
1.1 Research Objective
1.2 Scope of the Study
Chapter 2 Research Methodology
2.1 Research Process
2.2 Market Research Process
2.3 Market Research Approach
2.4 Data Sources
2.5 Assumptions & Limitations
Chapter 3 Executive Summary
3.1 Clinical Investigate Site Network Market Snapshot
Chapter 4 Market Variables and Scope
4.1 Introduction of Clinical Investigate Site Network
4.2 Classification and Scope
Chapter 5 COVID 19 Impact on Clinical Investigate Site Network Market
5.1 COVID-19 Landscape: Clinical Investigate Site Network Industry Impact
5.2 COVID 19 - Impact Assessment for the Healthcare Industry
5.3 Covid-19 Impact: Global Major Government Policy
5.4 Market Trends and Clinical Investigate Site Network Opportunities in the COVID-19 Landscape
Chapter 6 Market Dynamics Analysis and Trends
6.1 Clinical Investigate Site Network Market Dynamics
6.1.1 Market Drivers
6.1.1.1 Driver 1
6.1.1.2 Driver 2
6.1.1.3 Driver 3
6.1.2 Market Restraints
6.1.2.1 Restraint 1
6.1.2.2 Restraint 2
6.1.3 Market Opportunities
6.1.3.1 Opportunity 1
6.1.3.2 Opportunity 2
Chapter 7 Competitive Landscape
7.1 Company Market Share/Positioning Analysis
7.2 Global Clinical Investigate Site Network Market Revenue (USD Million) Analysis by Player (2016-2021)
7.3 Key Strategies Adopted by Players
7.4 Vendor Landscape
7.4.1 List of Suppliers
7.4.2 List of Buyers
Chapter 8 Clinical Investigate Site Network Market, Therapeutic Areas
8.1 Clinical Investigate Site Network Market, by Therapeutic Areas, 2017-2030
8.1.1 Global Clinical Investigate Site Network Market Revenue and Growth Rate analysis by Therapeutic Areas (2017-2030)
8.1.2 Global Clinical Investigate Site Network Market Revenue Share (%) by Therapeutic Areas in 2019 and 2027
8.1.3 Oncology
8.1.4 Hematology
8.1.5 Infectious Diseases
8.1.6 Others
Chapter 9 Clinical Investigate Site Network Market, End User
9.1 Clinical Investigate Site Network Market, by End User, 2017-2030
9.1.1 Global Clinical Investigate Site Network Market Revenue and Growth Rate analysis by End User (2017-2030)
9.1.2 Global Clinical Investigate Site Network Market Revenue Share (%) by End User in 2019 and 2027
9.1.3 Sponsors
9.1.4 CRO
Chapter 10 Global Clinical Investigate Site Network Market Analysis by Region
10.1 Global Clinical Investigate Site Network Market Analysis by Regions (2017-2030)
10.1.1 Global Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3 Global Clinical Investigate Site Network Market Analysis by Regions (2017-2030)
10.3.1 Global Clinical Investigate Site Network Market Size Comparison by Regions (2017-2030)
10.3.2 North America Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.3 North America Clinical Investigate Site Network Market Revenue and Forecast, by country (2017-2030)
10.3.3.1 US Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.3.2 Canada Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.4 Europe Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.5 Europe Clinical Investigate Site Network Market Revenue Comparison by Country (2017-2030)
10.3.6 Europe Clinical Investigate Site Network Market Revenue and Forecast, by country (2017-2030)
10.3.6.1 Germany Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.6.2 UK Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.6.3 France Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.7 Asia Pacific Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.8 Asia Pacific Clinical Investigate Site Network Market Revenue Comparison by Country (2017-2030)
10.3.9 Asia Pacific Clinical Investigate Site Network Market Revenue and Forecast, by country (2017-2030)
10.3.9.1 China Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.9.2 Japan Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.9.3 India Clinical Investigate Site Network Market Revenue and Forecast (2017-2030) 74
10.3.9.4 Southeast Asia Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.10 Latin America Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.11 Latin America Clinical Investigate Site Network Market Revenue, Production and Forecast, by country (2017-2030)
10.3.12 Latin America Clinical Investigate Site Network Market Revenue and Forecast, by country (2017-2030)
10.3.12.1 Brazil Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.12.2 Rest of LATAM Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.13 Middle East and Africa Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.14 MEA Clinical Investigate Site Network Market Revenue and Forecast, by country (2017-2030)
10.3.15 Middle East and Africa Clinical Investigate Site Network Market Revenue and Forecast, by country (2017-2030)
10.3.15.1 GCC Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.15.2 South Africa Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.15.3 North Africa Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
10.3.15.4 Rest of MEA Clinical Investigate Site Network Market Revenue and Forecast (2017-2030)
Chapter 11 Global Clinical Investigate Site Network Market, Regional Estimates and Trend Forecast
11.1 North America
11.1.1 North America Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.1.2 North America Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.1.3 U.S.
11.1.3.1 U.S. Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.1.3.2 U.S. Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.1.4 Canada
11.1.4.1 Canada Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.1.4.2 Canada Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.2 Europe
11.2.1 Europe Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.2.2 Europe Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.2.3 Germany
11.2.3.1 Germany Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.2.3.2 Germany Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.2.4 UK
11.2.4.1 UK Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.2.4.2 UK Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.2.5 France
11.2.5.1 France Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.2.5.2 France Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.2.6 Rest of Europe
11.2.6.1 Rest of Europe Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.2.6.2 Rest of Europe Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.3 Asia Pacific
11.3.1 Asia Pacific Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.3.2 Asia Pacific Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.3.3 China
11.3.3.1 China Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.3.3.2 China Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.3.4 Japan
11.3.4.1 Japan Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.3.4.2 Japan Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.3.5 India
11.3.5.1 India Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.3.5.2 India Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.3.6 Southeast Asia
11.3.6.1 Southeast Asia Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.3.6.2 Southeast Asia Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.3.7 Rest of APAC
11.3.7.1 Rest of APAC Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.3.7.2 Rest of APAC Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.4 Latin America
11.4.1 Latin America Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.4.2 Latin America Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.4.3 Brazil
11.4.3.1 Brazil Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.4.3.2 Brazil Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.4.4 Rest of LATAM
11.4.4.1 Rest of LATAM Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.4.4.2 Rest of LATAM Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.5 Middle East and Africa
11.5.1 Middle East and Africa Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.5.2 Middle East and Africa Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.5.3 GCC
11.5.3.1 GCC Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.5.3.2 GCC Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
11.5.4 Rest of MEA
11.5.4.1 Rest of MEA Clinical Investigate Site Network Market Revenue (USD Million) by Therapeutic Areas (2017-2030)
11.5.4.2 Rest of MEA Clinical Investigate Site Network Market Revenue (USD Million) by End User (2017-2030)
Chapter 12 Company Profile
12.1 ICON plc
12.1.1 Company Overview
12.1.2 Business Outline
12.1.3 Product Offerings
12.1.4 Financial Performance
12.1.5 Revenue, and Gross Margin (2016-2021)
12.1.1 Recent Initiatives
12.2 MERIDIAN CLINICAL RESEARCH
12.2.1 Company Overview
12.2.2 Business Outline
12.2.3 Product Offerings
12.2.4 Financial Performance
12.2.5 Revenue, and Gross Margin (2016-2021)
12.2.6 Recent Initiatives
12.3 IQVIA Inc.
12.3.1 Company Overview
12.3.2 Business Outline
12.3.3 Product Offerings
12.3.4 Financial Performance
12.3.5 Revenue, and Gross Margin (2016-2021)
12.3.6 Recent Initiatives
12.4 Clinedge
12.4.1 Company Overview
12.4.2 Business Outline
12.4.3 Product Offerings
12.4.4 Financial Performance
12.4.5 Revenue, and Gross Margin (2016-2021)
12.4.6 Recent Initiatives
12.5 WCG
12.5.1 Company Overview
12.5.2 Business Outline
12.5.3 Product Offerings
12.5.4 Financial Performance
12.5.5 Revenue, and Gross Margin (2016-2021)
12.5.6 Recent Initiatives
12.6 ClinChoice
12.6.1 Company Overview
12.6.2 Business Outline
12.6.3 Product Offerings
12.6.4 Financial Performance
12.6.5 Revenue, and Gross Margin (2016-2021)
12.7 Access Clinical Research
12.7.1 Company Overview
12.7.2 Business Outline
12.7.3 Product Offerings
12.7.4 Financial Performance
12.7.5 Revenue, and Gross Margin (2016-2021)
12.8 FOMAT Medical Research INC.
12.8.1 Company Overview
12.8.2 Business Outline
12.8.3 Product Offerings
12.8.4 Financial Performance
12.8.5 Revenue, and Gross Margin (2016-2021)
12.9 SGS
12.9.1 Company Overview
12.9.2 Business Outline
12.9.3 Product Offerings
12.9.4 Financial Performance
12.9.5 Revenue, and Gross Margin (2016-2021)
12.10 KV Clinical
12.10.1 Company Overview
12.10.2 Business Outline
12.10.3 Product Offerings
12.10.4 Financial Performance
12.10.5 Revenue, and Gross Margin (2016-2021)
12.11 SMO-Pharmina
12.11.1 Company Overview
12.11.2 Business Outline
12.11.3 Product Offerings
12.11.4 Financial Performance
12.11.5 Revenue, and Gross Margin (2016-2021)
12.12 Xylem Clinical Research
12.12.1 Company Overview
12.12.2 Business Outline
12.12.3 Product Offerings
12.12.4 Financial Performance
12.12.5 Revenue, and Gross Margin (2016-2021)
Chapter 13 Disclaimer
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers